The composite analysis was based on equal weighting of XbaI, BlnI and MLVA data and unweighted pair group method with arithmetic mean (UPGMA) clustering. Results Description of the data sets The 40 Salmonella serovar Enteritidis isolates selected for the analysis were all paired based on source of isolate. The pairs covered all
months with exception of August and the geographical zones; BKK (n = 14), 1 (n = 2), 3 (n = 2), 4 (n = 4), 10 (n = 12), 11 (n = 4), and 12 (n = 2) (Figure 1). Figure 1 A composite dendrogram based on PFGE and MLVA data containing 40 Salmonella serotype Enteritidis isolates from Thai patients. Selleckchem YAP-TEAD Inhibitor 1 antimicrobial resistance The MIC determination of the 40 Salmonella VX-689 concentration serovar Enteritidis isolates revealed eight antimicrobial resistance profiles. The most common profile exhibited resistance to three antimicrobials: ampicillin, ciprofloxacin, and nalidixic acid. Nineteen (48%) and nine (23%) isolates belonged to the most common (AMP-CIP-NAL)
and the second most common (CIP-NAL) resistance profiles, respectively (Table 1). Table 1 Frequency of the resistance profile per variable; specimen and geographical zone among Salmonella enterica serovar Enteritidis in Thai patients during 2008 Resistance profile No of isolates Specimen (No. (%)) Zone (No. (%)) Blood Faeces BKK 1 3 4 10 11 12 AMP-CIP-NAL 19 8 (42) 11 (58) 7 (37) 0 0 4 (21) 5 (26) 2 (11) 1 (5) CIP-NAL 9 3 (33) 6 (67) 2 (22) 2 (22) AZD0530 manufacturer 1 (11) 0 2 (22) 2 (22) 0 CIP-NAL-SMX-TET-TMP 2 1 (50) 1 (50) 1 (50) 0 0 0 1 (50) 0 0 AMP-CIP-COL-NAL 2 1
(50) 1 (50) 1 (50) 0 0 0 0 0 1 (50) AMP-CIP-STR 2 1 (50) 1 (50) 1 (50) 0 0 0 1 (50) 0 0 AMP-CIP-SPE-STR 1 1 (100) 0 0 0 0 0 1 (100) 0 0 CIP-NAL-TET 1 1 (100) 0 1 (100) 0 0 0 0 0 0 Pan-susceptible 4 4 (100) 0 1 (25) 0 1 (25) 0 2 (50) 0 0 Total 40 20 (50) 20 (50) 14 (35) 2 (5) 2 (5) 4 (10) 12 (30) 4 (10) 2 (5) Abbreviations: AMP, ampicillin; CIP, ciprofloxacin; COL, colistin; NAL, nalidixic acid; SPT, spectinomycin; STR, streptomycin; SMX, sulfamethoxazole; TET, tetracycline; TMP, trimethoprim. Ninety percent of the isolates (n = 36) were ciprofloxacin resistant (MIC 0.25 – 2 mg/L), and of these, 83% were also nalidixic acid resistant (MIC >64 mg/L). Seven percent of the isolates exhibited resistance to ciprofloxacin (MIC 1 mg/L) while susceptible to nalidixic acid (MIC 16 mg/L). Four strains (-)-p-Bromotetramisole Oxalate (10%) were pansusceptible. Overall, antimicrobial resistance was observed to ampicillin (60%), tetracycline (8%), streptomycin (8%), colistin (5%), sulfamethoxazole (5%), trimethoprim (5%), and spectinomycin (3%) (Table 1). The most common antimicrobial resistance profile (AMP-CIP-NAL), contained a mixture of stool 11/19 (58%) and blood 8/19 (42%) isolates. Profiles; AMP-CIP-NAL, CIP-NAL, CIP-NAL-SMX-TET-TMP, AMP-CIP-COL-NAL, AMP-CIP-STR contained both blood and stool isolates. However, profiles AMP-CIP-SPE-STR, CIP-NAL-TET, and pansuceptible were composed solely of blood isolates.